Trademark Overview
On Friday, February 28, 2025, a trademark application was filed for QS-ORAL with the United States Patent and Trademark Office. The USPTO has given the QS-ORAL trademark a serial number of 99061621. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, August 4, 2025. This trademark is owned by Q-VANT Biosciences, Inc.. The QS-ORAL trademark is filed in the Pharmaceutical Products category with the following description:
Oral vaccine preparations; Adjuvants for use with vaccines; Adjuvants for medical purposes; Human vaccine preparations; Vaccine adjuvants; Vaccine preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Plant extracts, other than essential oils,...
